Somagenetix Companies
Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses. Somagenetix's mission is to use genetically modified phagocytes to treat patients suffering from immunodeficiency, neurodegeneration, and cancer with brain metastases.
Connections
Headquarters:
Zürich, Zurich, Switzerland
Industry:
Other
Founded Date:
2018